Therefore, we hypothesize that, under the circumstances of progressing AD, the deteriorated mitochondrial functions alter the ionic environment in mitochondria which promotes the interactions of Aβ1–42 with cypD and 17β-HSD10. The gene discussed is HSD17B10; the disease is Alzheimer disease.